Acute interstitial nephritis secondary to esomeprazole.
Geevasinga
Nimeshan
N
Clinical School, Westmead Hospital, PO Box 533, Wentworthville, NSW 2145, Australia. ngeevasi@gmp.usyd.edu.au
Kairaitis
Lukas
L
Rangan
Gopala K
GK
Coleman
Patrick L
PL
D000208:Acute Disease; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000009:adverse effects*; D004415:Dyspepsia / Q000188:drug therapy; D064098:Esomeprazole / Q000009:adverse effects*; D005260:Female; D006417:Hematuria / Q000139:chemically induced; D006801:Humans; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D009395:Nephritis, Interstitial / Q000139:chemically induced*; D011241:Prednisone / Q000627:therapeutic use; D054328:Proton Pump Inhibitors; D014839:Vomiting / Q000139:chemically induced
D000893:Anti-Inflammatory Agents; D000897:Anti-Ulcer Agents; D054328:Proton Pump Inhibitors; D064098:Esomeprazole; D011241:Prednisone; D008775:Methylprednisolone